Johnson & Johnson (JNJ)

723,000.00
-13,310.00(-1.81%)
  • Volume:
    59
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    723,000.00 - 723,000.00

JNJ Overview

Prev. Close
-
Day's Range
723,000-723,000
Revenue
47.45B
Open
723,000
52 wk Range
588,340-820,020
EPS
6.98
Volume
59
Market Cap
1.96P
Dividend (Yield)
4.52
(2.71%)
Average Vol. (3m)
40
P/E Ratio
23.69
Beta
0.589
1-Year Change
19.69%
Shares Outstanding
2,629,179,895
Next Earnings Date
-
What is your sentiment on J&J?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Johnson & Johnson Analysis

Johnson & Johnson Company Profile

Johnson & Johnson Company Profile

Employees
141700
  • Type:Equity
  • Market:Colombia
  • ISIN:US4781601046

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Read More

Analyst Price Target

Average184.81 (+11.59% Upside)
High215
Low164
Price165.62
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesNeutralBuyBuy
Technical IndicatorsSellSellStrong Buy
SummaryNeutralNeutralStrong Buy
  • What happened to the price? It’s down but not because it dropped during market. My options still have their value even though price is different. Was there a dividend?
    0
    • i would say sisnce it already broke the 168 level of structure i would be hunting for the liquidity at 155-156 and that would be my target.
      0
      • is anybody else seeing a big head and shoulders on the daily chart as I am honestly looking for some feedback rather than making any claim one way or the other. Thanks in advance folks.
        0
        • first 155, after 140 target:))
          4
          • R u crazy
            0
        • 175,5 target!
          0
          • vaccines are problematic. High penalties will come from lawsuits. stock markets are falling. However, the stock is going up. god *****share
            4
            • Tomorrow is earnings report . Let wait for report.. if below forcast we can short it on cfd ... Also the company is paying $99m to West Virginia..... That a negative report I guess...
              4
              • I want to buy
                2
                • JnJ is buy and hold dude, enjoy divis. It grows slowly in a sustainable way
                  1
                  • thought tho that jnj will be on a good buy this season as they are about to improve on there vaccines
                    0